These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis. Denzer UW; Lüth S Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671 [TBL] [Abstract][Full Text] [Related]
6. Non-invasive evaluation of liver fibrosis using transient elastography. Castera L; Forns X; Alberti A J Hepatol; 2008 May; 48(5):835-47. PubMed ID: 18334275 [TBL] [Abstract][Full Text] [Related]
7. [Using non-invasive transient elastography for the assessment of hepatic fibrosis]. Luo JW; Shao JH; Bai J; Cui LG; Wang JR Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):395-7. PubMed ID: 16732926 [No Abstract] [Full Text] [Related]
8. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634 [TBL] [Abstract][Full Text] [Related]
9. [Non-invasive diagnosis of hepatic fibrosis]. Lu LG; Zeng MD Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):210-1. PubMed ID: 16556418 [No Abstract] [Full Text] [Related]
10. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. Pagadala M; Zein CO; McCullough AJ Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of liver fibrosis in clinical practice]. Abenavoli L; Leggio L; Gasbarrini G; Addolorato G Recenti Prog Med; 2006 Sep; 97(9):481-5. PubMed ID: 17017301 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis. Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196 [TBL] [Abstract][Full Text] [Related]
13. Implementing non-invasive markers for liver fibrosis in clinical practice. Sebastiani G; Alberti A J Hepatol; 2008 May; 48(5):880-1; author reply 881-3. PubMed ID: 18314216 [No Abstract] [Full Text] [Related]
14. Usefulness of fibrosis markers in liver diseases. Iaquinto G; Maio P; Ambrosone L; Magliocca M; Taccone W; Imparato L; Rambaldi M Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):233-4. PubMed ID: 9675667 [No Abstract] [Full Text] [Related]
15. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)? Chavez-Tapia NC; Tiribelli C Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116 [No Abstract] [Full Text] [Related]
16. Serum hyaluronic acid as a marker of hepatic fibrosis. Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578 [TBL] [Abstract][Full Text] [Related]
17. [Non-invasive detection of liver fibrosis in patients with chronic hepatitis C]. Aiglová K; Ehrmann J; Ehrmann J Cas Lek Cesk; 2007; 146(6):542-5. PubMed ID: 17650594 [TBL] [Abstract][Full Text] [Related]
18. Non-invasive assessment of chronic liver and gastric diseases. Plebani M; Basso D Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. Schmilovitz-Weiss H; Tovar A; Halpern M; Sulkes J; Braun M; Rotman Y; Tur-Kaspa R; Ben-Ari Z J Viral Hepat; 2006 Oct; 13(10):671-7. PubMed ID: 16970598 [TBL] [Abstract][Full Text] [Related]
20. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]